CRISPR Therapeutics AG (CRSP)

57.12 +0.94 (+1.67%) USD  |  NASDAQ  |  Jan 14, 14:59
More

CRISPR Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Novartis AG Upgrade
BeOne Medicines Ltd. Upgrade